
USD
$0.00
(0.00%
)At Close (As of Oct 31, 2025)
$9.56B
Market Cap
22.28
P/E Ratio
5.92
EPS
$246.19
52 Week High
$122.00
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) | 
|---|---|
| Gross Profit | $2.8B | 
| Total Revenue | $4B | 
| Cost Of Revenue | $1.2B | 
| Costof Goods And Services Sold | $1.2B | 
| Operating Income | $608M | 
| Selling General And Administrative | $1.6B | 
| Research And Development | $364M | 
| Operating Expenses | $2.2B | 
| Investment Income Net | - | 
| Net Interest Income | $20M | 
| Interest Income | $20M | 
| Interest Expense | - | 
| Non Interest Income | - | 
| Other Non Operating Income | - | 
| Depreciation | - | 
| Depreciation And Amortization | $145M | 
| Income Before Tax | $609M | 
| Income Tax Expense | $188M | 
| Interest And Debt Expense | - | 
| Net Income From Continuing Operations | $421M | 
| Comprehensive Income Net Of Tax | - | 
| Ebit | $672M | 
| Ebitda | $817M | 
| Net Income | $421M | 
| Field | Value (USD) | 
|---|---|
| Total Assets | $6.2B | 
| Total Current Assets | $2.5B | 
| Cash And Cash Equivalents At Carrying Value | $1B | 
| Cash And Short Term Investments | $1B | 
| Inventory | $254M | 
| Current Net Receivables | $1B | 
| Total Non Current Assets | $3.7B | 
| Property Plant Equipment | - | 
| Accumulated Depreciation Amortization Ppe | - | 
| Intangible Assets | $103M | 
| Intangible Assets Excluding Goodwill | $103M | 
| Goodwill | $443M | 
| Investments | - | 
| Long Term Investments | $0 | 
| Short Term Investments | $0 | 
| Other Current Assets | $165M | 
| Other Non Current Assets | - | 
| Total Liabilities | $2.4B | 
| Total Current Liabilities | $2B | 
| Current Accounts Payable | $109M | 
| Deferred Revenue | - | 
| Current Debt | - | 
| Short Term Debt | $31M | 
| Total Non Current Liabilities | $325M | 
| Capital Lease Obligations | $119M | 
| Long Term Debt | - | 
| Current Long Term Debt | - | 
| Long Term Debt Noncurrent | - | 
| Short Long Term Debt Total | $119M | 
| Other Current Liabilities | $471M | 
| Other Non Current Liabilities | $140M | 
| Total Shareholder Equity | $3.9B | 
| Treasury Stock | - | 
| Retained Earnings | $2.5B | 
| Common Stock | $7K | 
| Common Stock Shares Outstanding | $75M | 
| Field | Value (USD) | 
|---|---|
| Operating Cashflow | $738M | 
| Payments For Operating Activities | - | 
| Proceeds From Operating Activities | - | 
| Change In Operating Liabilities | - | 
| Change In Operating Assets | - | 
| Depreciation Depletion And Amortization | $145M | 
| Capital Expenditures | $116M | 
| Change In Receivables | - | 
| Change In Inventory | $25M | 
| Profit Loss | - | 
| Cashflow From Investment | -$255M | 
| Cashflow From Financing | -$356M | 
| Proceeds From Repayments Of Short Term Debt | - | 
| Payments For Repurchase Of Common Stock | - | 
| Payments For Repurchase Of Equity | - | 
| Payments For Repurchase Of Preferred Stock | - | 
| Dividend Payout | - | 
| Dividend Payout Common Stock | - | 
| Dividend Payout Preferred Stock | - | 
| Proceeds From Issuance Of Common Stock | - | 
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - | 
| Proceeds From Issuance Of Preferred Stock | - | 
| Proceeds From Repurchase Of Equity | -$353M | 
| Proceeds From Sale Of Treasury Stock | - | 
| Change In Cash And Cash Equivalents | - | 
| Change In Exchange Rate | - | 
| Net Income | $421M | 
| Field | Value (USD) | 
|---|---|
| Gross Profit | $2.8B | 
| Total Revenue | $4B | 
| Cost Of Revenue | $1.2B | 
| Costof Goods And Services Sold | $1.2B | 
| Operating Income | $608M | 
| Selling General And Administrative | $1.6B | 
| Research And Development | $364M | 
| Operating Expenses | $2.2B | 
| Investment Income Net | - | 
| Net Interest Income | $20M | 
| Interest Income | $20M | 
| Interest Expense | - | 
| Non Interest Income | - | 
| Other Non Operating Income | - | 
| Depreciation | - | 
| Depreciation And Amortization | $145M | 
| Income Before Tax | $609M | 
| Income Tax Expense | $188M | 
| Interest And Debt Expense | - | 
| Net Income From Continuing Operations | $421M | 
| Comprehensive Income Net Of Tax | - | 
| Ebit | $672M | 
| Ebitda | $817M | 
| Net Income | $421M | 
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Align Technology Inc. is a premier provider of innovative dental solutions, best known for its transformative Invisalign clear aligners and cutting-edge 3D digital scanning technologies. Based in San Jose, California, the company is strategically positioned to capitalize on the increasing demand for discreet orthodontic options globally. With a strong emphasis on research and development, Align Technology is dedicated to refining its products and services, ensuring they remain at the forefront of orthodontic innovation while fostering long-term growth and solidifying its market leadership.